Linagliptin, sold under the brand name Trajenta among others, is a medication used to treat diabetes mellitus type 2. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is used together with exercise and diet. It is not recommended in type 1 diabetes. It is taken by mouth.
Common side effects include inflammation of the n...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion